Integrin α(v)β(3)-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy

Rationale: Radiotherapy combined with immunotherapy has revealed promising outcomes in both preclinical studies and ongoing clinical trials. Targeted radionuclide therapy (TRT) is a branch of radiotherapy concerned with the use of radioisotopes, radiolabeled molecules or nanoparticles that deliver p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haojun, Zhao, Liang, Fu, Kaili, Lin, Qiuming, Wen, Xuejun, Jacobson, Orit, Sun, Long, Wu, Hua, Zhang, Xianzhong, Guo, Zhide, Lin, Qin, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831469/
https://www.ncbi.nlm.nih.gov/pubmed/31695808
http://dx.doi.org/10.7150/thno.39203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831469/
https://www.ncbi.nlm.nih.gov/pubmed/31695808
http://dx.doi.org/10.7150/thno.39203

Ejemplares similares